YOLFTbeta
Hunan Jiudian Pharmaceutical Co Ltd

Hunan Jiudian Pharmaceutical Co Ltd

300705 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

10.09CNY-0.18 (-1.75%)

Price History

Full chart

Market Stats

Previous Close10.27
Open10.26
Day Range10.09 – 10.32
52-Week Range9.26 – 16.87
Volume2.90M
Market Cap5.54B
P/E (TTM)14.38
Forward P/E0.00
EPS0.77
Dividend Yield3.61%
Beta-0.14
50-Day Avg11.10
200-Day Avg12.90

About

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system and metabolic, nervous system, cardiovascular system medications, musculoskeletal, anti-infective, respiratory system medications, blood and hematopoietic system, and reproductive and urinary system and hormone drugs. In addition, the company offers CMO/CDMO; software development and technical; and pharmaceutical retail services. Hunan Jiudian Pharmaceutical Co., Ltd. was founded in 2001 and is based in Changsha, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOGuo Wang
  • Employees2.30K
  • HeadquartersBuilding A1, Wukuang Lugu Science and Technology Industry Park, Changsha, China, 410205, China
  • Websitehttps://www.hnjiudian.com

Leadership

  • Guo WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue241.41M266.49M290.49M376.40M534.52M801.38M924.06M978.16M1.63B2.33B2.69B2.93B3.11B
Growth (%)-+10.39%+9.01%+29.57%+42.01%+49.93%+15.31%+5.85%+66.40%+42.92%+15.75%+8.85%+6.15%
Cost of Revenue108.71M129.05M140.32M182.89M257.77M324.15M302.45M253.29M365.47M522.52M621.79M790.88M841.68M
Gross Profit132.70M137.44M150.18M193.51M276.74M477.23M621.61M724.87M1.26B1.80B2.07B2.14B2.27B
Gross Margin54.97%51.58%51.70%51.41%51.77%59.55%67.27%74.11%77.55%77.54%76.91%73.01%72.94%
Operating Expense95.42M92.64M104.69M132.69M201.90M396.98M558.72M633.15M1.04B1.51B1.68B1.56B1.69B
Operating Income37.28M44.80M45.49M60.82M74.84M80.25M62.90M91.72M225.83M291.31M394.37M574.98M583.19M
Operating Margin15.44%16.81%15.66%16.16%14.00%10.01%6.81%9.38%13.87%12.52%14.65%19.62%18.75%
EBITDA46.59M58.58M57.78M74.89M87.37M96.02M90.15M126.39M264.80M338.49M446.50M633.88M665.65M
EBITDA Margin19.30%21.98%19.89%19.90%16.35%11.98%9.76%12.92%16.27%14.55%16.58%21.63%21.40%
Net Income36.26M41.24M44.64M54.53M68.57M71.99M55.07M82.26M204.25M269.70M368.26M512.38M472.82M
Net Income Margin15.02%15.47%15.37%14.49%12.83%8.98%5.96%8.41%12.55%11.59%13.68%17.48%15.20%
R&D12.71M19.25M24.27M18.07M28.57M57.49M109.80M81.68M146.26M201.26M254.12M245.97M218.41M
R&D as % of Total Revenue5.27%7.22%8.36%4.80%5.34%7.17%11.88%8.35%8.99%8.65%9.44%8.39%7.02%
Interest Expense2.06M1.31M943.45K1.36M710.59K1.40M4.75M5.38M16.13M18.42M11.06M18.74M14.99M
Interest Expense % of Total Revenue0.86%0.49%0.32%0.36%0.13%0.17%0.51%0.55%0.99%0.79%0.41%0.64%0.48%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets252.15M268.57M318.32M397.03M769.20M943.21M1.07B1.13B1.75B2.30B2.87B3.37B4.02B
Total Liabilities76.30M58.71M63.81M73.60M108.95M225.05M310.23M295.04M645.90M747.05M897.93M846.40M1.23B
Total Equity175.94M209.87M254.51M323.43M660.26M718.16M761.87M835.68M1.10B1.55B1.97B2.53B2.66B
Cash42.98M27.85M33.97M70.80M298.43M170.56M131.58M135.26M398.41M345.84M425.05M443.31M453.70M
Total Debt30.00M15.00M20.00M20.00M4.00M79.69M140.16M88.42M328.58M316.44M384.38M293.77M-
Net Debt-12.98M-12.85M-13.97M-50.80M-294.43M-90.87M8.58M-46.83M-69.83M-29.40M4.84M-149.54M29.01M

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow30.69M30.11M32.20M55.18M80.42M68.23M90.74M149.99M190.87M268.99M431.19M746.36M647.06M
Investing Cash Flow-42.51M-26.08M-30.16M-31.41M-97.76M-256.27M-178.93M-78.31M-229.56M-431.35M-424.58M-651.60M-
Financing Cash Flow56.08M-19.16M4.08M13.06M242.97M60.16M44.98M-65.50M283.56M121.02M73.55M-76.45M-
Capital Expenditure45.57M26.50M29.59M31.41M97.76M257.26M181.99M78.35M125.93M413.38M426.82M397.87M652.89M
Free Cash Flow-14.88M3.61M2.60M23.77M-17.34M-189.03M-91.25M71.64M64.94M-144.39M4.37M348.50M-5.83M
Dividends Paid2.06M4.99M922.89K13.65M676.73K15.53M11.03M8.45M10.09M61.25M94.62M115.71M160.92M
FCF to OCF-48.47%12.00%8.09%43.08%-21.56%-277.03%-100.56%47.76%34.02%-53.68%1.01%46.69%-0.90%
Dividend Paid to FCF-13.88%138.07%35.45%57.42%-3.90%-8.22%-12.09%11.79%15.54%-42.42%2166.69%33.20%-2759.64%

Earnings

Report DateFeb 27, 2018Apr 26, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Apr 26, 2019Aug 20, 2019Oct 30, 2019Dec 31, 2019Apr 28, 2020Aug 22, 2020Oct 30, 2020Mar 1, 2021Apr 28, 2021Aug 9, 2021Oct 25, 2021Dec 31, 2021Apr 26, 2022Jul 29, 2022Oct 27, 2022Dec 31, 2022Apr 14, 2023Aug 15, 2023Oct 23, 2023Jan 25, 2024Apr 24, 2024Jun 30, 2024Oct 28, 2024Dec 31, 2024Apr 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------
EPS Actual0.070.040.030.040.060.030.060.030.040.030.110.100.080.200.200.170.080.110.230.240.320.190.350.330.170.360.330.340.120.250.330.220.130.110.21
Surprise-----------------------------------
TimingPre-marketAfter-hours---Pre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap5.54B
Enterprise Value5.65B
Trailing P/E14.38
Forward P/E0.00
Price / Sales1.92
Price / Book2.13
EPS0.77
Book Value5.25
Revenue (TTM)2.89B
Gross Profit (TTM)1.96B
EBITDA544.87M
Profit Margin11.82%
Operating Margin16.59%
Return on Equity12.50%
Return on Assets6.39%
Shares Outstanding500.29M
Shares Float259.23M
Beta-0.14
Dividend Yield3.61%
Dividend Rate0.40
Payout Ratio59.03%

Dividends

20261×
0.40May 28, 2026
20251×
0.31May 26, 2025
20241×
0.23May 24, 2024
20231×
0.17May 15, 2023
20221×
0.13May 27, 2022
20211×
0.02May 19, 2021
20201×
0.02May 20, 2020
20191×
0.02May 28, 2019
20181×
0.03May 16, 2018

Stock Splits

  • May 24, 20241.4:1
  • May 27, 20221.4:1
  • May 16, 20182:1